The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization
Abstract
There are growing data to suggest that tissue hypoxia represents a critical force that drives adult vasculogenesis. Vascular endothelial growth factor (VEGF) expression is dramatically up‐regulated by hypoxia and results in enhanced neovascularization. Although the role of VEGF in angiogenesis has been well characterized, its role in adult vasculogenesis remains poorly understood. We used two distinct murine bone marrow transplantation (BMT) models to demonstrate that increased VEGF levels at the site of tumor growth promoted vasculogenesis in vivo . This effect of VEGF was downstream of its effect to enhance either mobilization or survival of circulating endothelial progenitor cells (EPCs). Both VEGFR1 (flt1) and VEGFR2 (flk1) are expressed on culture expanded human EPCs. Previous studies suggest that the effect of VEGF on endothelial cell migration is primarily mediated via VEGFR2; however, VEGF‐induced EPC migration in vitro was mediated by both receptors, suggesting that VEGF‐VEGFR1 interactions in EPCs are distinct from differentiated endothelial cells. We used specific blocking antibodies to these receptors to demonstrate that VEGFR1 plays an important role in human EPC recruitment to tumors. These findings were further supported by our finding that tumor‐associated placental growth factor (PlGF), a VEGFR1‐specific agonist, increased tumor vasculogenesis in a murine BMT model. We further showed that both VEGF receptors were necessary for the formation of functional vessels derived from exogenously administered human ex vivo expanded EPCs. Our data suggest local VEGF and/or PlGF expression promote vasculogenesis; VEGF plays a role in EPC recruitment and subsequent formation of functional vessels.—Li, B., Sharpe, E. E., Maupin, A., Teleron, A. A., Pyle, A., Carmeliet, P., Young, P. P. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 20, E664–E676 (2006)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931 · cited 4×
“In the heterozygous mouse (flk/lacZ), expression of lacZ is subject to regulation by an EC-specific promoter (32).”
BackgroundMethodInfluentialCirculating endothelial progenitor cells, vascular function, and cardiovascular risk
Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022287 · Cited by 3,423
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J. M., & Asahara, T. (1999) · Nature Medicine · doi:10.1038/7434 · Cited by 2,423
Endothelial Progenitor Cells: Characterization and Role in Vascular Biology
Urbich, C., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000137877.89448.78 · Cited by 2,369
Assmus, B., Schächinger, V., Teupe, C., Britten, M., Lehmann, R., Döbert, N., Grünwald, F., Aicher, A., Urbich, C., Martin, H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000043246.74879.cd · Cited by 2,201
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization
Kalka, C., Masuda, H., Takahashi, T., Kalka-Moll, W. M., Silver, M., Kearney, M., Li, T., Isner, J. M., & Asahara, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3422 · Cited by 1,863
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration
Rafii, S., & Lyden, D. (2003) · Nature Medicine · doi:10.1038/nm0603-702 · Cited by 1,577
Risau, W., & Flamme, I. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.000445 · Cited by 1,406
Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A., & Marme, D. (1996) · Blood · doi:10.1182/blood.v87.8.3336.bloodjournal8783336 · Cited by 1,356
Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction
Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Honma, T., Katoh, A., Sasaki, K.-I., Shimada, T., Oike, Y., & Imaizumi, T. (2001) · Circulation · doi:10.1161/hc2301.092122 · Cited by 1,185
Yamaguchi, J.-I., Kusano, K. F., Masuo, O., Kawamoto, A., Silver, M., Murasawa, S., Bosch-Marce, M., Masuda, H., Losordo, D. W., Isner, J. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000055313.77510.22 · Cited by 1,149
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction
Schächinger, V., Assmus, B., Britten, M. B., Honold, J., Lehmann, R., Teupe, C., Abolmaali, N. D., Vogl, T. J., Hofmann, W.-K., Martin, H., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.014 · Cited by 1,088
Role of vascular endothelial growth factor in regulation of physiological angiogenesis
Ferrara, N. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1358 · Cited by 1,085
Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,068
Self-citationClinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004 · cited 1×
“The proangiogenic functions of VEGF have been extensively studied (21, 54).”
BackgroundMurdoch, C., Giannoudis, A., & Lewis, C. E. (2004) · Blood · doi:10.1182/blood-2004-03-1109 · Cited by 915
Gill, M., Dias, S., Hattori, K., Rivera, M. L., Hicklin, D., Witte, L., Girardi, L., Yurt, R., Himel, H., & Rafii, S. (2001) · Circulation Research · doi:10.1161/01.res.88.2.167 · Cited by 798
Hattori, K., Dias, S., Heissig, B., Hackett, N. R., Lyden, D., Tateno, M., Hicklin, D. J., Zhu, Z., Witte, L., Crystal, R. G., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1005 · Cited by 687
Hattori, K., Heissig, B., Wu, Y., Dias, S., Tejada, R., Ferris, B., Hicklin, D. J., Zhu, Z., Bohlen, P., Witte, L., et al. (2002) · Nature Medicine · doi:10.1038/nm740 · Cited by 633
Iwaguro, H., Yamaguchi, J.-I., Kalka, C., Murasawa, S., Masuda, H., Hayashi, S.-I., Silver, M., Li, T., Isner, J. M., & Asahara, T. (2002) · Circulation · doi:10.1161/hc0602.103673 · Cited by 588
Kalka, C., Masuda, H., Takahashi, T., Gordon, R., Tepper, O., Gravereaux, E., Pieczek, A., Iwaguro, H., Hayashi, S.-I., Isner, J. M., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1198 · Cited by 564
De Falco, E., Porcelli, D., Torella, A. R., Straino, S., Iachininoto, M. G., Orlandi, A., Truffa, S., Biglioli, P., Napolitano, M., Capogrossi, M. C., et al. (2004) · Blood · doi:10.1182/blood-2003-12-4423 · Cited by 521
Crosby, J. R., Kaminski, W. E., Schatteman, G., Martin, P. J., Raines, E. W., Seifert, R. A., & Bowen-Pope, D. F. (2000) · Circulation Research · doi:10.1161/01.res.87.9.728 · Cited by 519
Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice
Schatteman, G. C., Hanlon, H. D., Jiao, C., Dodds, S. G., & Christy, B. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9087 · Cited by 482
Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance
Hristov, M., & Weber, C. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00474.x · Cited by 477
Tepper, O. M., Capla, J. M., Galiano, R. D., Ceradini, D. J., Callaghan, M. J., Kleinman, M. E., & Gurtner, G. C. (2005) · Blood · doi:10.1182/blood-2004-03-1051 · Cited by 445
Autiero, M., Luttun, A., Tjwa, M., & Carmeliet, P. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00263.x · Cited by 357
Self-citationDrake, C. J., & Little, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7657 · Cited by 324
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
Brantley, D. M., Cheng, N., Thompson, E. J., Lin, Q., Brekken, R. A., Thorpe, P. E., Muraoka, R. S., Cerretti, D. P., Pozzi, A., Jackson, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205679 · Cited by 316
MOORE, M. A. S., HATTORI, K., HEISSIG, B., SHIEH, J. ‐., DIAS, S., CRYSTAL, R. G., & RAFII, S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03572.x · Cited by 289
Kanno, S., Oda, N., Abe, M., Terai, Y., Ito, M., Shitara, K., Tabayashi, K., Shibuya, M., & Sato, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203533 · Cited by 285
Cathepsin L is required for endothelial progenitor cell–induced neovascularization
Urbich, C., Heeschen, C., Aicher, A., Sasaki, K.-I., Bruhl, T., Farhadi, M. R., Vajkoczy, P., Hofmann, W. K., Peters, C., Pennacchio, L. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1182 · Cited by 284
Ii, M., Nishimura, H., Iwakura, A., Wecker, A., Eaton, E., Asahara, T., & Losordo, D. W. (2005) · Circulation · doi:10.1161/01.cir.0000157144.24888.7e · Cited by 246
The role of FGF and VEGF in angioblast induction and migration during vascular development
Poole, T. J., Finkelstein, E. B., & Cox, C. M. (2001) · Developmental Dynamics · doi:10.1002/1097-0177(2000)9999:9999<::aid-dvdy1087>3.0.co;2-2 · Cited by 244
Beta-glucuronidase deficiency mucopolysaccharidosis: methods for enzymatic diagnosis.
Glaser, J. H., & Sly, W. S. (1973) · PubMed · Cited by 188
Vascular leukocytes contribute to tumor vascularization
Conejo-Garcia, J. R., Buckanovich, R. J., Benencia, F., Courreges, M. C., Rubin, S. C., Carroll, R. G., & Coukos, G. (2005) · Blood · doi:10.1182/blood-2004-05-1906 · Cited by 184
Rafii, S., Heissig, B., & Hattori, K. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301723 · Cited by 175
Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor
Thomas, J., Liu, F., & Link, D. C. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200205000-00002 · Cited by 167
Constitutive and inducible expression and regulation of vascular endothelial growth factor
Xie, K., Wei, D., Shi, Q., & Huang, S. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.04.003 · Cited by 163
Isolation of endothelial cells and their progenitor cells from human peripheral blood
Boyer, M., Townsend, L. E., Vogel, L. M., Falk, J., Reitz-Vick, D., Trevor, K. T., Villalba, M., Bendick, P. J., & Glover, J. L. (2000) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(00)70080-2 · Cited by 159
Placenta growth factor is over-expressed and has prognostic value in human breast cancer
Parr, C., Watkins, G., Boulton, M. E., Cai, J., & Jiang, W. G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.07.022 · Cited by 140
Transplanted human bone marrow contributes to vascular endothelium
Jiang, S., Walker, L., Afentoulis, M. E., Anderson, D. A., Jauron-Mills, L., Corless, C. L., & Fleming, W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404398101 · Cited by 136
VEGF Regulates Cell Behavior during Vasculogenesis
Drake, C. J., LaRue, A. C., Ferrara, N., & Little, C. D. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9744 · Cited by 124
Endothelial Progenitor Cells: More Than an Inflammatory Response?
Rabelink, T. J., de Boer, H. C., de Koning, E. J. P., & van Zonneveld, A. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000124891.57581.9f · Cited by 104
Nitric oxide synthase activity.
Frederiks, W. M. (1996) · Journal of Histochemistry & Cytochemistry · doi:10.1177/44.11.8918910 · Cited by 96
Different Pathways of Macromolecule Extravasation from Hyperpermeable Tumor Vessels
Feng, D., Nagy, J. A., Dvořàk, A. M., & Dvorak, H. F. (2000) · Microvascular Research · doi:10.1006/mvre.1999.2207 · Cited by 96
Endothelial progenitor cells’ ‘homing’ specificity to brain tumors
Moore, X. L., Lu, J., Sun, L. J., Zhu, C.-J., Tan, P., & Wong, M.-C. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302151 · Cited by 90
Endothelial progenitor cells: A source for therapeutic vasculogenesis?
Rumpold, H. F., Wolf, D. G. F., Koeck, R., & Gunsilius, E. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00475.x · Cited by 89
Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A
Bautch, V. L., Redick, S. D., Scalia, A., Harmaty, M. A., Carmeliet, P., & Rapoport, R. (2000) · Blood · doi:10.1182/blood.v95.6.1979 · Cited by 65
Self-citationVincent, L., Jin, D. K., Karajannis, M. A., Shido, K., Hooper, A. T., Rashbaum, W. K., Pytowski, B., Wu, Y. L., Hicklin, D. J., Zhu, Z., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3598 · Cited by 60
Hofling, A., Devine, S., Vogler, C., & Sands, M. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.03.013 · Cited by 48
Solanilla, A., Grosset, C. F., Duchez, P., Legembre, P., Pitard, V., Dupouy, M., Belloc, F., Viallard, J., Reiffers, J. J., Boiron, J.-M., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04155.x · Cited by 48
Hofling, A. A., Vogler, C. A., Creer, M. H., & Sands, M. S. (2003) · Blood · doi:10.1182/blood-2002-08-2597 · Cited by 47
Freeman, B. J., Roberts, M. S., Vogler, C. A., Nicholes, A., Hofling, A. A., & Sands, M. S. (1999) · Blood · doi:10.1182/blood.v94.6.2142 · Cited by 42
VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels
Argraves, W. S., LaRue, A. C., Fleming, P. A., & Drake, C. J. (2002) · Developmental Dynamics · doi:10.1002/dvdy.10162 · Cited by 39
Teleron, A. A., Carlson, B., & Young, P. P. (2004) · Transfusion · doi:10.1111/j.1537-2995.2005.04191.x · Cited by 27
Self-citationAsaumi, N., Omoto, E., Mahmut, N., Katayama, Y., Takeda, K., Shinagawa, K., & Harada, M. (2001) · Annals of Hematology · doi:10.1007/s002770100309 · Cited by 22
Biodistribution and efficacy of donor t lymphocytes in a murine model of lysosomal storage disease
Young, P. P., Vogler, C. A., Hofling, A. A., & Sands, M. S. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00016-5 · Cited by 7
Self-citation
Cited by
Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., VandenBerg, S., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,130
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Fischer, C., Mazzone, M., Jonckx, B., & Carmeliet, P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2524 · Cited by 568
Self-citationJablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564
Mechanisms of Glioma-Associated Neovascularization
Hardee, M. E., & Zagzag, D. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.06.030 · Cited by 475
Cardiovascular Effects of Exercise Training: Molecular Mechanisms
Gielen, S., Schuler, G., & Adams, V. (2010) · Circulation · doi:10.1161/circulationaha.110.939959 · Cited by 433
Metadata
- Authors
- Li, B., Sharpe, E. E., Maupin, A. B., Teleron, A. A., Pyle, A. L., Carmeliet, P., Young, P. P., Li, B., Sharpe, E. E., Maupin, A. B., Teleron, A. A., Pyle, A. L., Carmeliet, P., & Young, P. P.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2006-06-05
- Volume
- 20
- Issue
- 9
- Pages
- 1495-1497
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2154353368
- Cited by
- 324
- References
- 64
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.